Trial Profile
Phase I trial of LCT-Siro (sirolimus)
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis; Polycystic kidney disease; Renal transplant rejection
- Focus Adverse reactions
- Sponsors Veloxis Pharmaceuticals
- 04 Dec 2007 New trial record.